Ozempic (semaglutide) pill and injection are prescription medications used for type 2 diabetes to improve blood glucose levels and reduce the risk of heart attack, stroke, and the injection can also be used to slow kidney disease progression in certain type 2 diabetes patients
Without this extension, the patent would have expired on September 17, 2022, twenty years from its filing date
(NEJM 2023), where retatrutide 12 mg produced 24.2% mean body-weight loss at 48 weeks without a plateau [1]
The stocks were always freshly dissolved and immediately used in the cellular assays
This can result in aspiration pneumonitis, respiratory distress, or pneumonia, potentially complicating surgical recovery
Realistic expectations matter It is essential to keep expectations grounded